MWMartin K. Walz

Martin K. Walz

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Martin K. Walz has a total of 142 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Thoracoscopic parathyroidectomy: a 22-year experience

    by D. Buzanakov, P. F. Alesina, P. Kniazeva, M. K. Walz, П. Князєва

    Thoracoscopic parathyroidectomy (TP) is a preferred approach to the treatment of hyperparathyroidism (HPT), caused by hyperfunctioning parathyroid glands located in mediastinum, though the data on its feasibility and safety are scarce, due to the rarity of this condition. Objective — to assess the safety and feasibility of thoracoscopic parathyroidectomy. Materials and methods. A retrospective cohort included 25 patients (14 male, 11 female) of primary thoracoscopic parathyroidectomy performed in Kliniken Essen‑Mitte and Wuppertal Helios Hospital from August 2002 to December 2024. Out of the patients included in the study, 15 patients underwent TP as their initial operation for primary HPT (pHPT), 7 patients had persistent pHPT after cervical operations, one — recurrent pHPT, and two — recurrent secondary HPT. Median age was 60 years (range: 27—77 years). The mediastinal location of the parathyroid was suspected by (99m)Tc‑sestamibi (MIBI)‑scintigraphy in 18 cases, five cases were MIBI‑negative, and in two cases, no MIBI‑scintigraphy was performed. In all cases, parathyroid localization was confirmed by 4D Computed tomography (CT) scan (n=17), magnetic resonance imaging (MRI) (n=3) or Positron emission tomography (PET‑CT) (n=5). Pre‑ and postoperative levels of serum calcium and parathormone, histopathological reports, and surgery protocols were analyzed. Intraoperative parathyroid hormone (PTH) level was measured with a rapid assay to confirm the success of the procedure 15 minutes after resection. Results. During the investigated period, 26 thoracoscopic operations were performed. Overall success rate was 84.6% as in 4 cases no hyperfunctioning parathyroid tissue was thoracoscopically removed. In the first case, a cervical approach was required; in the second one, the patient was reoperated thoracoscopically one year later; in the third case, the operation resulted in the normalization of serum calcium level despite the absence of parathyroid tissue in the pathological specimen. In one more case, the patient demonstrated postoperatively elevated PTH level with normal serum calcium level. Median duration of operations was 80 minutes (range: 20—320 minutes). No perioperative deaths or major complications occurred. No conversion to sternotomy or thoracotomy was performed. A complication rate was 4.2%, including one case of chylothorax, followed by a successful retroperitoneoscopic ligation of the thoracic lymphatic duct, and one case of temporary phrenic palsy. Median postoperative hospital stay was 2 days (range 2—6 days). No readmissions due to any reasons after discharge were registered. Conclusions. Thoracoscopic parathyroidectomy is safe and feasible, being the optimal treatment option in most cases of mediastinal parathyroid adenomas. However, it requires precise preoperative localization to guarantee the success of the treatment.

  • Top Cited Papers
    Open Access

    Surgery for advanced adrenal malignant disease: recommendations based on European Society of Endocrine Surgeons consensus meeting

    by Radu Mihai, Carmela De Crea, Carole Guerin, Francesca Torresan, Orhan Agcaoglu, Razvan Simescu, Martin K Walz

    Incidental radiological abnormalities of the adrenal glands can be identified in between 1 in 10 and 1 in 20 CT images in adults1. The current challenge is to institute cost-efficient clinical pathways, to avoid excessive investigations in patients with benign non-functional adrenal tumours, to ensure that functional tumours are identified and treated, and to avoid missing the very rare but extremely aggressive adrenocortical carcinomas (ACCs).


  • Open Access

    Primary perioperative haemodynamic effects of ß-receptor blockade in patients with catecholamine-secreting tumours

    by Harald Groeben, Bente J. Nottebaum, Aarne Feldheiser, Steffen Buch, Piero F. Alesina, Martin K. Walz


  • Retroperitoneoscopic Adrenalectomy in Adrenocortical Carcinoma with Tumor Thrombus in Inferior Vena Cava: One Step Further in Minimally Invasive Endocrine Surgery

    by Martin K. Walz, Isariya Jongekkasit, Pier F. Alesina

    Introduction: Nowadays, the standard procedures of removing benign adrenal tumors are minimally invasive surgical techniques using the laparoscopic or the retroperitoneoscopic route. In adrenal carcinomas most surgeons still prefer open accesses. Some adrenal carcinomas create a tumor thrombus (TT) in big veins. We present the case of adrenal cancer with a TT in the inferior vena cava (IVC) that was removed through the retroperitoneoscopic route. Patient and Method: In a 43-year-old female patient a 4 cm mass of the right adrenal gland was incidentally diagnosed. Hormonal tests were negative. Magnet resonance imaging showed a small TT in the IVC. We decided to remove the adrenal tumor and TT by the posterior retroperitoneoscopic approach.1,2 Three ports were introduced underneath the 11th and 12th rib. The retroperitoneal space was opened by meticulous dissection under carbon dioxide pressure of 20 mm Hg. The IVC was circularly dissected and clamped inferiorly and superiorly to the adrenal tumor. After lateral mobilization, the adrenal mass was placed into a plastic bag. IVC was opened by circular excision of the junction of the adrenal vein. By this maneuver the TT was mobilized to glide into the bag. Fragmentation of tumor tissue and tumor cell spillage could be avoided. The defect of the IVC was closed by running suture. After declamping of the IVC, free blood flow was maintained. The tumor was removed by fragmentation out of the bag. No drain was used. Results: Operating time was 170 minutes. Blood loss was neglectable. Mobilization and food intake started on day of surgery. The postoperative course was uneventful. Histopathology report described an adrenocortical cancer with confluenting necroses and a Ki-67 proliferation rate of 15%. Postoperatively, adjuvant mitotane therapy was started. After a follow-up of 18 months, patient is disease free without any evidence of local or distant recurrence. Summary: This video shows—for the first time—an oncologic minimally invasive extirpation of adrenal carcinoma with a TT in the vena cava. Furthermore, it demonstrates principle and method of safe and bloodless surgery by vessel control, useful in minimally invasive and in open surgery. No competing financial interests exist. Authors' Contributions: All three authors participated in collection, selection, and editing of the video material. Consent: Patient gave written informed consent to show surgery and other pictures, including her body and face. Runtime of video: 11 mins 57 secs


  • Open Access

    Differentiating Benign from Malignant Adrenocortical Tumors by a Single Morphological Parameter—a Clinicopathological Study on 837 Adrenocortical Neoplasias

    by Martin K. Walz, Klaus A. Metz, Sarah Theurer, Cathrin Myland, Pier F. Alesina, Kurt W. Schmid

    The morphological differentiation between benign and malignant adrenocortical tumors is an ongoing problem in diagnostic pathology. In recent decades the complex scoring systems have been widely used to calculate the probability of malignancy in adrenocortical tumors on the basis of a variety of histomorphological parameters. We herewith present a substantially simplified method to diagnose adrenocortical carcinoma by a single histomorphological parameter on a consecutive series of more than 800 adrenocortical tumors. Between January 2000 and May 2019, altogether 2305 adrenalectomies for of all types of diseases were removed, approximately 98% by minimally invasive approaches. After exclusion of pheochromocytomas, adrenal ganglioneuromas, adrenal metastases, Cushing’s disease related specimens, and Conn’s adenomas, the present series finally consisted of 837 adrenocortical tumors. All tumors were analyzed by experienced pathologists of a single institution using standard histopathological methods (Hematoxylin-Eosin and Ki67 stained sections). Clinical and histopathologic data were prospectively collected and retrospectively analyzed. Clinically, 385 patients had 420 functioning tumors (FT), and 417 had non-functioning adrenal tumors (NFT). The mean size of FT was 3.8 ± 1.4 cm (range 0.5–16 cm) and for NFT 4.5 ± 1.6 cm (range 1.5–18 cm). Histomorphologically, 32 adrenal tumors were classified as adrenocortical carcinoma (ACC; 3.8%). In all 32 cases (tumor size 9.1 ± 4.0 cm, range 3–18 cm), confluenting tumor necrosis could be demonstrated. The remaining 805 tumors (control group) completely lacked this highly reproducible single morphological feature. Ki67 levels above 10% were found in 31 of 32 ACCs and never in adrenocortical adenomas (ACA). With a mean follow-up of 8.2 years, 24 out of 32 patients primarily diagnosed as ACC developed distant metastases (75.0%), whereas all patients in the control group remained free of local or distant recurrence. We conclude that a single morphological parameter (confluenting tumor necrosis) is sufficient to predict a poor clinical course in adrenocortical tumors. The histomorphological diagnosis of this parameter is straightforward and highly reproducible.


  • Minimal-invasive Chirurgie retroperitonealer Paragangliome

    by M. K. Walz

    Retroperitoneale Paragangliome sind seltene Tumoren mit den Eigenschaften adrenaler Phäochromozytome. Sie kommen entweder sporadisch oder im Zusammenhang hereditärer Syndrome vor. Ihre Diagnostik umfasst endokrinologische Methoden und bildgebende Verfahren. Primäre Therapieoption ist die Operation, wobei aus unserer Sicht die minimal-invasiven Methoden als die Verfahren der ersten Wahl gelten. Dabei sollten infrarenale Paragangliome transperitoneal laparoskopisch entfernt werden und suprarenale Tumoren retroperitoneoskopisch angegangen werden. Retroperitoneal paragangliomas are rare tumors with the characteristics of adrenal pheochromocytomas. They may occur sporadically or in conjunction with hereditary syndromes. Diagnostic methods in paragangliomas include testing of catecholamine secretion and imaging procedures. The first choice treatment is surgical removal, which in the author’s opinion is preferably by minimally invasive approaches. Infrarenal paragangliomas should be excised using a laparoscopic transabdominal procedure. For suprarenal tumors the retroperitoneoscopic approach should be used.


  • Minimally Invasive Surgery (MIS) in Children and Adolescents with Pheochromocytomas and Retroperitoneal Paragangliomas: Experiences in 42 Patients

    by Martin K. Walz, Laura D. Iova, Judith Deimel, Hartmut P. H. Neumann, Birke Bausch, Stefan Zschiedrich, Harald Groeben, Pier F. Alesina

    Background: Pheochromocytomas (PH) and paragangliomas (PGL) are rare tumours in children accounting for about 1% of the paediatric hypertension. While minimally invasive surgical techniques are well established in adult patients with PH, the experience in children is extremely limited. To the best of our knowledge, we herewith present the largest series of young patients operated on chromaffin tumours by minimally invasive access.Materials: In the setting of a prospective study (1/2001–12/2016), 42 consecutive children and adolescents (33 m, 9 f) were operated on. Thirty‐seven patients (88%) suffered from inherited diseases. Twenty‐six patients had PH, 11 presented retroperitoneal PGL, and five patients suffered from both. Altogether, 70 tumours (mean size 2.7 cm) were removed (45 PH, 25 PGL). All operations were performed by a minimally invasive access (retroperitoneoscopic, laparoscopic, extraperitoneal). Partial adrenalectomy was the preferred procedure for PH (31 out of 39 patients). Twenty patients received α‐receptor blockade preoperatively.Results: One patient died after induction of anaesthesia due to cardiac arrest. All other complications were minor. Conversion to open surgery was necessary in two cases with PGL. Median operating time for unilateral PH was 55 min, in bilateral cases 125, 143 min in PGs, and 180 min in combined cases. Median blood loss was 20 ml (range 0–1000). Blood transfusion was necessary in two cases. Intraoperative, systolic peak pressure was 170 ± 39 mmHg with α‐receptor blockade and 191 ± 33 mmHg without α‐receptor blockade (p = 0.41). The median post‐operative hospital stay was 3 days. After a mean follow‐up of 8.5 years, two patients presented ipsilateral recurrence (after partial adrenalectomy). All patients with bilateral PH (n = 13) are steroid independent post‐operatively.Conclusions: PH and PGL in children and adolescents should preferably be removed by minimally invasive surgery. Partial adrenalectomy provides long‐term steroid independence in bilateral PH and a low rate of (ipsilateral) recurrence. α‐Receptor blockade may not be necessary in these patients.


  • A simplified surgical technique for recurrent inguinal hernia repair following total extraperitoneal patch plastic

    by P. Knyazeva, P. F. Alesina, P. Stadelmeier, M. Anaya-Cortez, M. K. Walz


  • Open Access

    The Effect of Early Thyroidectomy on the Course of Active Graves’ Orbitopathy (GO): A Retrospective Case Study

    by M. Meyer zu Horste, K. Pateronis, M. K. Walz, P. Alesina, K. Mann, M. Schott, J. Esser, A. K. Eckstein

    The aim of the work was to investigate the effect of early thyroidectomy on the course of active Graves’ orbitopathy (GO) in patients with low probability of remission [high TSH receptor antibody (TRAb) serum levels, severe GO] compared to that of continued therapy with antithyroid drugs. Two cohorts were evaluated retrospectively (total n=92 patients with active GO, CAS≥4). Forty-six patients underwent early thyroidectomy (Tx-group) 6±2 months after initiation of antithyroid drug (ATD) therapy, while ATD was continued for another 6±2 months in the ATD-group (n=46). These controls were consecutively chosen from a database and matched to the Tx-group. GO was evaluated (activity, severity, TRAb) at baseline and at 6 month follow-up. At baseline, both cohorts were virtually identical as to disease severity, activity and duration, as well as prior anti-inflammatory treatment, age, gender, and smoking behavior. At 6 month follow-up, NOSPECS severity score was significantly decreased within each group, but did not differ between both groups. However, significantly more patients of the Tx-group presented with inactive GO (89.1 vs. 67.4%, * p=0.02), and mean CAS score was significantly lower in Tx-group (2.1) than in ADT-group (2.8; * p=0.02) at the end of follow-up. TRAb levels declined in both groups (Tx-group: from 18.6 to 5.2 vs. ATD-group: 12.8–3.2 IU/l, p0=0.07, p6months=0.32). Residual GO activity was lower in Tx-group, associated with a higher rate of inactivation of GO. This allows an earlier initiation of ophthalmosurgical rehabilitation in patients with severe GO, which may positively influence quality of life of the patients.